clinical lab test references
BiomarkersLabs.com

Lab Testing for Practitioners

BML-HRF-009female hormonesUSA

Progesterone Test

The progesterone test measures serum progesterone, the principal hormone of the luteal phase and early pregnancy. Its main clinical use is confirming ovulation, with a mid-luteal rise providing biochemical evidence that a corpus luteum has formed.

1

Biomarkers

Blood (serum)

Sample

1–3 business days

Turnaround

No — however, collection timing relative to the menstrual cycle is essential and should be documented (typically mid-luteal, around 7 days before the expected period)

Fasting

What is the Progesterone test?

The Progesterone Test measures serum progesterone, the principal hormone of the luteal phase and early pregnancy. Its dominant clinical role is the confirmation of ovulation: a mid-luteal rise demonstrates that a corpus luteum has formed and is producing hormone, making it a cornerstone of subfertility assessment. Within the reproductive endocrine landscape, progesterone is interpreted strictly in relation to cycle timing and is rarely informative without it. It complements measurements of LH, FSH, and oestradiol in characterising the menstrual cycle, supports monitoring of ovulation-induction and luteal-support protocols in assisted reproduction, and assists in evaluating early pregnancy where low levels may signal a non-viable or ectopic gestation. In postmenopausal and non-pregnant contexts, progesterone is used selectively rather than as a routine screen.

What does the Progesterone test measure?

1
P4(Progesterone)
Range: Follicular: <1.0 ng/mL (<3.2 nmol/L); Luteal: 2.0–25.0 ng/mL (6.4–79.5 nmol/L); Postmenopausal: <0.5 ng/mL (<1.6 nmol/L) # REVIEWER FLAG: Reference ranges are phase- and assay-dependent — reviewer to confirm against LabCorp's assay-specific intervals.Optimal: Mid-luteal >10 ng/mL is commonly used as supportive evidence of adequate ovulation # REVIEWER FLAG: Mid-luteal ovulation threshold is convention-dependent and not universally standardised — reviewer to confirm against current guidance.ng/mL / nmol/L

Progesterone is a C21 steroid hormone synthesised principally by the corpus luteum after ovulation, by the adrenal cortex, and by the placenta during pregnancy. It is derived from pregnenolone and serves as a precursor for other steroid hormones. Circulating progesterone is largely bound to albumin and corticosteroid-binding globulin, with a short half-life of minutes to hours. Levels fluctuate markedly across the menstrual cycle, peaking in the mid-luteal phase, and rise substantially in pregnancy.

Progesterone measurement confirms ovulation, with a mid-luteal rise being the classical biochemical evidence that ovulation has occurred. It supports luteal-phase assessment in subfertility, monitoring of assisted reproduction and progesterone supplementation, and evaluation of early pregnancy viability. Because levels change rapidly across the cycle, the timing of collection relative to the menstrual cycle is essential for meaningful interpretation.

Why is the Progesterone test ordered?

  • Confirmation of ovulation in subfertility assessment — a mid-luteal progesterone, drawn around 7 days before the expected period, provides biochemical evidence that ovulation has occurred
  • Investigation of luteal-phase adequacy in women with recurrent early pregnancy loss or suspected luteal insufficiency
  • Monitoring of ovulation-induction cycles and luteal support during assisted reproductive technology protocols
  • Evaluation of early pregnancy viability where low progesterone may support suspicion of a failing or ectopic pregnancy, interpreted alongside serial hCG
  • Assessment of menstrual irregularity or amenorrhoea as part of a reproductive hormone profile with LH, FSH, and oestradiol
  • Monitoring of progesterone supplementation in patients receiving exogenous progesterone for luteal support or hormone therapy
  • Investigation of suspected congenital adrenal hyperplasia or adrenal steroidogenic disorders as part of a broader steroid panel

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

No — however, collection timing relative to the menstrual cycle is essential and should be documented (typically mid-luteal, around 7 days before the expected period)

Collection method

Venipuncture at patient service centre

Turnaround

1–3 business days

Collection notes

Document the cycle day and any exogenous progesterone or ovulation-induction therapy. For ovulation confirmation, draw in the mid-luteal phase. Advise patients to withhold high-dose biotin supplementation for 48–72 hours prior to collection to avoid immunoassay interference.

Specimen requirements

Minimum 0.5 mL serum. Separate serum from cells per LabCorp protocol. Specimen stable refrigerated; follow LabCorp transport guidelines.

What can affect Progesterone results?

variableTiming within the menstrual cycle

Progesterone varies more than tenfold across the cycle, peaking mid-luteal and falling to baseline in the follicular phase. A specimen drawn at the wrong cycle point is uninterpretable; collection timing must be documented relative to the menstrual cycle.

elevatesExogenous progesterone or progestin therapy

Supplemental progesterone raises measured levels directly, while some synthetic progestins may or may not cross-react with the assay depending on its design. Treatment and product should be documented.

elevatesPregnancy

Progesterone rises progressively in pregnancy due to corpus luteum and then placental production, with values far exceeding luteal-phase concentrations.

variablePulsatile luteal secretion

Corpus luteum progesterone is secreted in pulses, so a single mid-luteal value can vary substantially within the same day. A borderline result may warrant repeat sampling.

elevatesOvulation-induction medications

Clomiphene, letrozole, and gonadotrophin stimulation can produce multiple corpora lutea, elevating luteal progesterone above natural-cycle expectations.

variableHigh-dose biotin supplementation

Biotin can interfere with streptavidin-biotin immunoassay platforms, producing falsely altered progesterone depending on assay architecture. Patients should withhold high-dose biotin for 48–72 hours before collection.

What do Progesterone results mean?

Elevated

Elevated progesterone in the luteal phase confirms ovulation and an active corpus luteum. Markedly elevated values may reflect pregnancy, multiple corpora lutea from ovulation induction, exogenous progesterone, or, rarely, a progesterone-producing ovarian or adrenal lesion.

Normal

Interpretation depends entirely on cycle phase. A follicular-phase value is expected to be low, while a mid-luteal value above the ovulation threshold supports normal ovulatory function. A result without documented cycle timing cannot be classified reliably.

Reduced

A low mid-luteal progesterone suggests anovulation, a luteal-phase defect, or mistimed sampling. In early pregnancy, low progesterone raises concern for a non-viable or ectopic gestation and should be interpreted alongside serial hCG.

Note: Progesterone is meaningless without cycle context — the same value can be normal or abnormal depending on timing. Pulsatile secretion means a single value may not represent the true luteal peak, and exogenous progesterone or biotin can distort results. Always interpret alongside the menstrual history and, where relevant, hCG.

Frequently asked questions

Its principal use is confirming ovulation. A mid-luteal rise in progesterone provides biochemical evidence that a corpus luteum has formed and is producing hormone, indicating ovulation has occurred.

How to access the Progesterone test

The Progesterone reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page